Identification of Kinase Targets for Enhancing the Antitumor Activity of Eribulin in Triple-Negative Breast Cell Lines.

MLA

Xie, Xuemei, et al. “Identification of Kinase Targets for Enhancing the Antitumor Activity of Eribulin in Triple-Negative Breast Cell Lines.” Biomedicines, vol. 11, no. 3, Feb. 2023. EBSCOhost, https://doi.org/10.3390/biomedicines11030735.

APA

Xie, X., Lee, J., Fuson, J. A., Liu, H., Iwase, T., Yun, K., Margain, C., Tripathy, D., & Ueno, N. T. (2023). Identification of Kinase Targets for Enhancing the Antitumor Activity of Eribulin in Triple-Negative Breast Cell Lines. Biomedicines, 11(3). https://doi.org/10.3390/biomedicines11030735

Chicago

Xie, Xuemei, Jangsoon Lee, Jon A Fuson, Huey Liu, Toshiaki Iwase, Kyuson Yun, Cori Margain, Debu Tripathy, and Naoto T Ueno. 2023. “Identification of Kinase Targets for Enhancing the Antitumor Activity of Eribulin in Triple-Negative Breast Cell Lines.” Biomedicines 11 (3). doi:10.3390/biomedicines11030735.